Path: cantaloupe.srv.cs.cmu.edu!crabapple.srv.cs.cmu.edu!fs7.ece.cmu.edu!europa.eng.gtefsd.com!howland.reston.ans.net!hsdndev!enterprise.bih.harvard.edu!rind
From: rind@enterprise.bih.harvard.edu (David Rind)
Newsgroups: sci.med
Subject: Re: erythromycin
Date: 15 Apr 1993 18:09:31 GMT
Organization: Beth Israel Hospital, Harvard Medical School, Boston Mass., USA
Lines: 11
Message-ID: <1qk8cr$h2q@hsdndev.harvard.edu>
References: <47974@sdcc12.ucsd.edu>
NNTP-Posting-Host: enterprise.bih.harvard.edu

In article <47974@sdcc12.ucsd.edu> wsun@jeeves.ucsd.edu (Fiberman) writes:
>Is erythromycin effective in treating pneumonia?

It depends on the cause of the pneumonia.  For treating bacterial
pneumonia in young otherwise-healthy non-smokers, erythromycin
is usually considered the antibiotic of choice, since it covers
the two most-common pathogens: strep pneumoniae and mycoplasma
pneumoniae.
-- 
David Rind
rind@enterprise.bih.harvard.edu
